Paroma Bhattacharya works as a content developer for allnewsmyway.com and a few other portals. A qualified post-graduate in the discipline of journalism and mass communication, writing comes as naturally to Paroma as a fish takes to water. Ever eager to pen down the happenings related to the worlds of health, technology, and business to name a few, Paroma rejuvenates herself by indulging in DIY activities, handicrafts, and cooking. She can be contacted at- [email protected] | https://twitter.com/paromab1/
The merger will create a Franco-German champion that challenges Chinese designs in the rail industry. German conglomerate, Siemens AG and French rail company Alstom SA are reportedly pushing ahead with the sale of train-equipment assets in a bid to re-claim their rail merger amidst European …
DNO previously required the support of 57.5% Faroe shareholders but now only requires 50%. DNO’s takeover attempts intensified after it lifted its stakes in Faroe. DNO ASA (DNO), a renowned Norwegian oil and gas operator, has reportedly announced that it now requires the support of …
The deal will grant Gilead rights over HOOKIPA’s immunization technologies for developing immunotherapies against HIV and HBV. HOOKIPA Pharma Inc., a clinical-stage company developing novel immunotherapies targeting infectious diseases and cancers, has recently acquired its first research milestone through a collaboration and license agreement with …
Wichita-based largest first-tier aerostructures manufacturer Spirit AeroSystems has announced that it has reached a long term agreement with Boeing, its largest customer, for a wide range of commercial airplane programs. Financial terms regarding the deal were not yet disclosed by the company. Reportedly, Spirit revealed …
The outcome of the Vectra(R) clinical studies were published in the journal Rheumatology. The adjusted Vectra(R) test is significantly more effective than conventional methods in predicting radiographic progression in individuals suffering from Rheumatoid Arthritis. Myriad Genetics, Inc. (Myriad), a leading American molecular diagnostic firm, has …
DUSA Pharmaceuticals, a wholly-owned Sun Pharma subsidiary, had filed a patent infringement lawsuit against Biofrontera for using its proprietary trade secrets. The lawsuit claimed trade secret misappropriation as well as patent infringement of the firm’s photodynamic therapy patents. Sun Pharmaceutical Industries Ltd. (Sun Pharma), an …
China is currently in the news for launching a new high-speed railway line that links over 50 scenic tourist spots in the Yangtze River Delta. Having 10 stations, the new railway line extends up to 265km, where trains travel at a speed of 250kmh. According …
By signing a collaboration deal with Agenus, Gilead is continuing to foray into the field of cancer immunotherapy. The partnership aims to develop & commercialize around five new immuno-oncology (I-O) treatments. Gilead Sciences, Inc., (Gilead), a renowned American biotechnology company, has reportedly announced that it …